Background A wide range of drugs have been studied for first trimester medical abortion.
Studies evaluating different regimens, including combination mifepristone and misoprostol …

Background Mifepristone and misoprostol are recommended for second-trimester medical
abortion, but consensus is unclear on the ideal regimen. Objectives The objectives were to …

Objective To describe the efficacy, safety, and acceptability of medical abortion in the late
first trimester. Study design We searched PubMed and Cochrane databases for articles in …

BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …

OBJECTIVE: To estimate the clinical benefit of pretreatment with mifepristone followed by
misoprostol compared with misoprostol alone for second-trimester abortion. METHODS: Two …

Objective The objective was to describe the efficacy of medical abortion using mifepristone
and misoprostol for gestations less than 6 weeks. Study design We searched PubMed and …

Aim To compare the efficacy of different intervals of misoprostol administration
(simultaneously vis-à-vis 24 h), after mifepristone, in women undergoing medical termination …

Aim The aim of the present study was to investigate the safety and efficacy of low‐dose
mifepristone combined with self‐administered misoprostol for termination of early …

Objective To compare the efficacy of 100 mg and 200 mg of mifepristone and 24‐and 48‐
hour intervals to administration of 800μg vaginal misoprostol for termination of early …

BACKGROUND: Vaginal misoprostol has been shown to be an effective single agent for
medical abortion. This randomized, double-blinded, placebo-controlled trial compared a …